Skip to main content
. 2021 Jul 7;11:14042. doi: 10.1038/s41598-021-93546-5

Table 1.

Characteristics of the study population.

Parameters COVID-19 with fatigue group COVID-19 without fatigue group Control group P value
N = 12 N = 15 N = 12
Age (years) 48 [12] 39 [10] 43 [9] 0.085
Female 5 (41.7) 9 (60.0) 7 (58.3) 0.594
Hypertension 2 (16.7) 1 (6.7) 1 (8.3) 0.688
Diabetes 0 (0) 1 (6.7) 0 (0) 0.377
Respiratory diseases 2 (16.7) 1 (6.7) 0 (0) 0.224
Previous cardiovascular events 0 (0) 0 (0) 0 (0)
Previous oxygen therapy#* 2 (18.2) 1 (7.1) 0.399
ICU hospitalization 0 (0) 0 (0)
Neurological symptoms after COVID-19 0 (0) 0 (0)
Cardiac damages after COVID-19 0 (0) 0 (0)
Loss of taste and smell* 6 (54.6) 8 (53.3) 0.951
Weight before COVID-19 (kg)* 85 [31] 66 [28] 0.062
Weight at NoL test (kg) 85 [37] 63 [26] 80 [21] 0.101
Height (m) 1.75 [0.2] 1.66 [0.1] 1.76 [0.2] 0.499
BMI before COVID-19 (kg/m2)* 26.4 [8.6] 23.4 [6.9] 0.229
BMI at NoL test (kg/m2) 25.2 [8.8] 22.7 [5.9] 25.0 [7.1] 0.246
Loss of weight (median %)* 0 [9.3] 0 [9.8] 0.632
HR (bpm) 73 [17] 70 [11] 72 [22] 0.708
SBP (mmHg) 130 [20] 130 [33] 121 [29] 0.749
DBP (mmHg) 89 [12] 70 [19] 76 [22] 0.056
NIJMEGEN score* 36 [15] 20 [18] 0.002
PCL-5 score* 31 [18] 18 [19] 0.001
30 s of up and down test* 4 [3] 5 [2] 0.192
Oxygen saturation (%) 98 [3] 98 [3] 98 [2] 0.663
Duration from first symptoms of plong COVID-19 (months)* 7.5 [1.7] 7.0 [2.2] 0.157

BMI: body mass index.

HR: heart rate.

SBP: systolic blood pressure.

DBP: diastolic blood pressure.

ICU: intensive care unit.

*Only comparison between “covid-19 participants with fatigue and covid-19 participants without fatigue”.

#Oxygen therapy was administrated through low-flow nasal cannula.

Categorical values were presented as number and percentage, continuous variables were presented as median and interquartile range (IQR).

HHS Vulnerability Disclosure